Kevin Bitterman, Director at Genocea Biosciences, holds 1.15M shares in Disc Medicine (Ticker: IRON), holds 2.52M shares in Akero Therapeutics (Ticker: AKRO), holds 4.16M shares in Editas Medicine (Ticker: EDIT). Most recently, Kevin Bitterman Bought ― shares of Disc Medicine on Jun 20, 2024 for an estimated value of 8.00M.